Skip navigation
Skip navigation

Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer

Hoy, Julia; Neeman, Teresa; Stuart-Harris, Robin; Davis, Alison


Aim: Previous studies have shown that adjuvant chemotherapy in early breast cancer (EBC) may increase the risk of venous thromboembolism (VTE). Clinical experience suggests the combination of 5-fluorouracil, epirubicin and cyclophosphamide (FEC) may be associated with a higher frequency of VTE than other regimens. This study aims to investigate the use of adjuvant FEC compared with other adjuvant regimens in the development of VTE in patients with EBC. Methods: A retrospective auditwas...[Show more]

CollectionsANU Research Publications
Date published: 2009
Type: Journal article
Source: Asia-Pacific Journal of Clinical Oncology
DOI: 10.1111/j.1743-7563.2009.01205.x


File Description SizeFormat Image
01_Hoy_Risk_of_venous_thromboembolism_2009.pdf113.18 kBAdobe PDF    Request a copy
02_Hoy_Risk_of_venous_thromboembolism_2009.pdf84.25 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  23 August 2018/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator